SIGA Technologies Inc Market Cap ($228.08 Million)
Market Cap & Net Worth: SIGA Technologies Inc (SIGA)
SIGA Technologies Inc market cap. SIGA Technologies Inc (NASDAQ:SIGA) has a market capitalization of $228.08 Million ($228.08 Million) as of October 31, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #15922 globally and #3795 in its home market, demonstrating a 1.92% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying SIGA Technologies Inc's stock price $3.18 by its total outstanding shares 71724097 (71.72 Million).
SIGA Technologies Inc Market Cap History (2015–2026)
SIGA Technologies Inc market cap history from 2015 to 2026. Data shows growth from $24.36 Million to $228.08 Million (13.21% CAGR). Check today's stock price for SIGA Technologies Inc for real-time trading data and today's change.
Index Memberships
SIGA Technologies Inc is a constituent of 3 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.62 Trillion | 0.01% | #432 of 976 |
|
NASDAQ Composite
IXIC
|
$40.85 Trillion | 0.00% | #1562 of 3165 |
|
NASDAQ Biotechnology
NBI
|
$1.84 Trillion | 0.01% | #219 of 263 |
Weight: SIGA Technologies Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
SIGA Technologies Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how SIGA Technologies Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Also see SIGA Technologies Inc cash conversion from operations for how efficiently the company converts equity into cash flow.
Latest Price to Sales (P/S) Ratio
4.63x
SIGA Technologies Inc's market cap is 4.63 times its annual revenue
Latest Price to Earnings (P/E) Ratio
18.81x
SIGA Technologies Inc's market cap is 18.81 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $167.05 Million | $14.99 Million | -$39.70 Million | 11.15x | N/A |
| 2017 | $281.30 Million | $12.27 Million | -$36.24 Million | 22.93x | N/A |
| 2018 | $458.21 Million | $477.05 Million | $421.81 Million | 0.96x | 1.09x |
| 2019 | $276.66 Million | $26.74 Million | -$7.24 Million | 10.35x | N/A |
| 2020 | $421.67 Million | $124.96 Million | $56.34 Million | 3.37x | 7.48x |
| 2021 | $436.17 Million | $133.67 Million | $69.45 Million | 3.26x | 6.28x |
| 2022 | $454.29 Million | $110.78 Million | $33.90 Million | 4.10x | 13.40x |
| 2023 | $374.14 Million | $139.92 Million | $68.07 Million | 2.67x | 5.50x |
| 2024 | $431.06 Million | $138.72 Million | $59.21 Million | 3.11x | 7.28x |
| 2025 | $438.23 Million | $94.60 Million | $23.30 Million | 4.63x | 18.81x |
Competitor Companies of SIGA by Market Capitalization
Companies near SIGA Technologies Inc in the global market cap rankings as of October 31, 2026. See how leveraged is SIGA Technologies Inc's balance sheet to understand what proportion of total assets are financed by equity.
Key companies related to SIGA Technologies Inc by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #515 globally with a market cap of $52.60 Billion USD.
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #536 globally with a market cap of $50.42 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #600 globally with a market cap of $45.38 Billion USD ( CN¥310.15 Billion CNY).
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #626 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #515 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #536 | GALDERMA GROUP AG | NYSE:GALDY | $50.42 Billion | $45.98 |
| #600 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $45.38 Billion | CN¥48.62 |
| #626 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €17.90 |
Market Capitalization of SIGA Technologies Inc (2015–2026)
Market capitalization of SIGA Technologies Inc from 2015 to today. Between 2015 and today, SIGA Technologies Inc's market cap moved from $24.36 Million to $ 228.08 Million, with a yearly change of 13.21%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $228.08 Million | -47.95% |
| 2025 | $438.23 Million | +1.66% |
| 2024 | $431.06 Million | +15.21% |
| 2023 | $374.14 Million | -17.64% |
| 2022 | $454.29 Million | +4.16% |
| 2021 | $436.17 Million | +3.44% |
| 2020 | $421.67 Million | +52.41% |
| 2019 | $276.66 Million | -39.62% |
| 2018 | $458.21 Million | +62.89% |
| 2017 | $281.30 Million | +68.40% |
| 2016 | $167.05 Million | +585.81% |
| 2015 | $24.36 Million | -- |
End of Day Market Cap According to Different Sources
On Oct 30th, 2026 the market cap of SIGA Technologies Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $228.08 Million USD |
| MoneyControl | $228.08 Million USD |
| MarketWatch | $228.08 Million USD |
| marketcap.company | $228.08 Million USD |
| Reuters | $228.08 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About SIGA Technologies Inc
SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security market in the United States. The company's lead product is TPOXX, an antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc. was incorporated in 1995 and is headquartered in New York, New York.